ExeVir Bio fetches Series A

ExeVir Bio, a Belgian life sciences institute, has raised 23 million euros in Series A funding.

ExeVir Bio, a Belgian life sciences institute, has raised 23 million euros in Series A funding. Fund+ led the round with participation from VIB, UCB Ventures, the Belgian Federal Government via SFPI-FPIM, V-Bio Ventures and several Belgian family offices.

Source: Press Release